A study exploring the role of butyrate (a gut microbiota metabolite) in regulating B cells in NOD mice demonstrated that butyrate may ameliorate SS via reciprocal regulation of IL-10 and IL-17-producing B cells [33]. Here, IL17A is linked to synovial sarcoma.